These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 29142197)

  • 21. Human amyloidogenic light chain proteins result in cardiac dysfunction, cell death, and early mortality in zebrafish.
    Mishra S; Guan J; Plovie E; Seldin DC; Connors LH; Merlini G; Falk RH; MacRae CA; Liao R
    Am J Physiol Heart Circ Physiol; 2013 Jul; 305(1):H95-103. PubMed ID: 23624626
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An N-glycosylation hotspot in immunoglobulin κ light chains is associated with AL amyloidosis.
    Nevone A; Girelli M; Mangiacavalli S; Paiva B; Milani P; Cascino P; Piscitelli M; Speranzini V; Cartia CS; Benvenuti P; Goicoechea I; Fazio F; Basset M; Foli A; Nanci M; Mazzini G; Caminito S; Sesta MA; Casarini S; Rognoni P; Lavatelli F; Petrucci MT; Olimpieri PP; Ricagno S; Arcaini L; Merlini G; Palladini G; Nuvolone M
    Leukemia; 2022 Aug; 36(8):2076-2085. PubMed ID: 35610346
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Zebrafish model of amyloid light chain cardiotoxicity: regeneration versus degeneration.
    Mishra S; Joshi S; Ward JE; Buys EP; Mishra D; Mishra D; Morgado I; Fisch S; Lavatelli F; Merlini G; Dorbala S; MacRae CA; Liao R
    Am J Physiol Heart Circ Physiol; 2019 May; 316(5):H1158-H1166. PubMed ID: 30875258
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of mutations in the cellular internalization of amyloidogenic light chains into cardiomyocytes.
    Levinson RT; Olatoye OO; Randles EG; Howell KG; DiCostanzo AC; Ramirez-Alvarado M
    Sci Rep; 2013; 3():1278. PubMed ID: 23417147
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cu(II) Binding Increases the Soluble Toxicity of Amyloidogenic Light Chains.
    Russo R; Romeo M; Schulte T; Maritan M; Oberti L; Barzago MM; Barbiroli A; Pappone C; Anastasia L; Palladini G; Diomede L; Ricagno S
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055136
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unfolding Cardiac Amyloidosis -From Pathophysiology to Cure.
    Ablasser K; Verheyen N; Glantschnig T; Agnetti G; Rainer PP
    Curr Med Chem; 2019; 26(16):2865-2878. PubMed ID: 29303069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nanobodies counteract the toxicity of an amyloidogenic light chain by stabilizing a partially open dimeric conformation.
    Broggini L; Barzago MM; Speranzini V; Schulte T; Sonzini F; Giono M; Romeo M; Milani P; Caminito S; Mazzini G; Rognoni P; Merlini G; Pappone C; Anastasia L; Nuvolone M; Palladini G; Diomede L; Ricagno S
    J Mol Biol; 2023 Dec; 435(24):168320. PubMed ID: 37865287
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Kinetic Stability of a Full-Length Antibody Light Chain Dimer Determines whether Endoproteolysis Can Release Amyloidogenic Variable Domains.
    Morgan GJ; Kelly JW
    J Mol Biol; 2016 Oct; 428(21):4280-4297. PubMed ID: 27569045
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protease-sensitive regions in amyloid light chains: what a common pattern of fragmentation across organs suggests about aggregation.
    Mazzini G; Ricagno S; Caminito S; Rognoni P; Milani P; Nuvolone M; Basset M; Foli A; Russo R; Merlini G; Palladini G; Lavatelli F
    FEBS J; 2022 Jan; 289(2):494-506. PubMed ID: 34482629
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systemic Amyloidosis Due to Clonal Plasma Cell Diseases.
    Bianchi G; Kumar S
    Hematol Oncol Clin North Am; 2020 Dec; 34(6):1009-1026. PubMed ID: 33099420
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular Mechanism of Pathogenesis and Treatment Strategies for AL Amyloidosis.
    Ikura H; Endo J; Kitakata H; Moriyama H; Sano M; Fukuda K
    Int J Mol Sci; 2022 Jun; 23(11):. PubMed ID: 35683015
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 18F-Florbetapir Binds Specifically to Myocardial Light Chain and Transthyretin Amyloid Deposits: Autoradiography Study.
    Park MA; Padera RF; Belanger A; Dubey S; Hwang DH; Veeranna V; Falk RH; Di Carli MF; Dorbala S
    Circ Cardiovasc Imaging; 2015 Aug; 8(8):. PubMed ID: 26259579
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiac Light Chain Amyloidosis: The Role of Metal Ions in Oxidative Stress and Mitochondrial Damage.
    Diomede L; Romeo M; Rognoni P; Beeg M; Foray C; Ghibaudi E; Palladini G; Cherny RA; Verga L; Capello GL; Perfetti V; Fiordaliso F; Merlini G; Salmona M
    Antioxid Redox Signal; 2017 Sep; 27(9):567-582. PubMed ID: 28132512
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of complementarity-determining regions 1 and 3 in pathologic amyloid formation by human immunoglobulin κ1 light chains.
    Klimtchuk ES; Peterle D; Bullitt E; Connors LH; Engen JR; Gursky O
    Amyloid; 2023 Dec; 30(4):364-378. PubMed ID: 37216473
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Conservative Point Mutation in a Dynamic Antigen-binding Loop of Human Immunoglobulin λ6 Light Chain Promotes Pathologic Amyloid Formation.
    Peterle D; Klimtchuk ES; Wales TE; Georgescauld F; Connors LH; Engen JR; Gursky O
    J Mol Biol; 2021 Dec; 433(24):167310. PubMed ID: 34678302
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Barriers to Small Molecule Drug Discovery for Systemic Amyloidosis.
    Morgan GJ
    Molecules; 2021 Jun; 26(12):. PubMed ID: 34208058
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Light chain mutations contribute to defining the fibril morphology in systemic AL amyloidosis.
    Karimi-Farsijani S; Pfeiffer PB; Banerjee S; Baur J; Kuhn L; Kupfer N; Hegenbart U; Schönland SO; Wiese S; Haupt C; Schmidt M; Fändrich M
    Nat Commun; 2024 Jun; 15(1):5121. PubMed ID: 38879609
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Harnessing Cardiac Regeneration as a Potential Therapeutic Strategy for AL Cardiac Amyloidosis.
    Joshi S; Evangelisti A; Liao R; Alexander KM
    Curr Cardiol Rep; 2020 Jan; 22(1):1. PubMed ID: 31932992
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Binding of nascent collagen by amyloidogenic light chains and amyloid fibrillogenesis in monolayers of human fibrocytes.
    Harris DL; King E; Ramsland PA; Edmundson AB
    J Mol Recognit; 2000; 13(4):198-212. PubMed ID: 10931557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A functional assay to identify amyloidogenic light chains.
    Martin EB; Williams AD; Heidel RE; Foster JS; Lands RH; Kennel SJ; Wall JS
    Amyloid; 2018 Jun; 25(2):93-100. PubMed ID: 29571269
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.